Medicare Enrolled
Dr. John Hill, MD
Family Medicine · Deland, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hill?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hill
Dr. John Hill is a family medicine specialist in Deland, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hill performed 30,761 Medicare services across 14,600 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hill received a total of $17,073 from 70 pharmaceutical and/or device companies across 1019 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hill is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in FL
$17,073 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 93242 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗30,761
Medicare services
Top 0% in FL for family medicine
14,600
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,619 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 3,961 | $88 | $275 |
| Chronic care management, first 20 min/month | 3,077 | $46 | $127 |
| Denosumab injection (Prolia/Xgeva) | 1,980 | $17 | $43 |
| Blood draw (venipuncture) | 1,473 | $8 | $25 |
| Office visit, established patient, complex (40-54 min) | 1,335 | $128 | $371 |
| Comprehensive metabolic blood panel | 1,288 | $10 | $31 |
| Complete blood count (CBC) with differential | 1,231 | $8 | $25 |
| Free thyroxine (T4) test | 1,062 | $9 | $29 |
| Lipid panel (cholesterol and triglycerides) | 1,056 | $13 | $40 |
| Ldl cholesterol level | 1,054 | $10 | $31 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 1,050 | $41 | $100 |
| Thyroid stimulating hormone (TSH) test | 1,015 | $16 | $50 |
| Hemoglobin A1c test (diabetes monitoring) | 987 | $10 | $29 |
| Annual wellness visit, follow-up | 673 | $126 | $260 |
| C-peptide (protein) level | 637 | $20 | $66 |
| Office visit, established patient (20-29 min) | 587 | $61 | $200 |
| Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | 528 | $44 | $100 |
| Annual alcohol misuse screening, 5 to 15 minutes | 482 | $18 | $37 |
| Annual depression screening | 459 | $18 | $37 |
| Chronic care management, additional 20 min/month | 452 | $36 | $96 |
| Vitamin B-12 level test | 386 | $15 | $46 |
| Detection test by immunoassay with direct visual observation for influenza virus | 372 | $16 | $53 |
| Folic acid level test | 364 | $14 | $44 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 315 | $40 | $151 |
| Vitamin D level test | 310 | $29 | $88 |
| Iron level test | 295 | $6 | $20 |
| Iron binding capacity test | 295 | $9 | $30 |
| Office visit, established patient (10-19 min) | 289 | $42 | $114 |
| Drug injection, under skin or into muscle | 280 | $10 | $30 |
| Ferritin level test (iron stores) | 278 | $13 | $41 |
| Psa (prostate specific antigen) measurement, free | 267 | $18 | $55 |
| PSA test (prostate cancer screening) | 232 | $18 | $55 |
| Prothrombin time test (blood clotting) | 221 | $4 | $26 |
| New patient office visit (45-59 min) | 158 | $103 | $433 |
| Urinalysis, manual | 139 | $3 | $35 |
| Transitional care management services for problem of high complexity | 129 | $212 | $575 |
| Injection, ketorolac tromethamine, per 15 mg | 118 | $0 | $56 |
| New patient office visit, complex (60-74 min) | 114 | $133 | $468 |
| Urine microalbumin test (kidney screening) | 107 | $6 | $37 |
| Electrocardiogram (EKG), 12-lead | 107 | $10 | $31 |
| Transitional care management services for problem of at least moderate complexity | 104 | $157 | $408 |
| Creatinine test (kidney function) | 103 | $5 | $35 |
| Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | 98 | $143 | $384 |
| Manual urinalysis test with examination using microscope, non-automated | 94 | $4 | $30 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 93 | $96 | $264 |
| Uric acid level test | 86 | $4 | $15 |
| Testosterone (hormone) level, total | 82 | $25 | $77 |
| Ceftriaxone antibiotic injection | 79 | $0 | $44 |
| Magnesium level test | 75 | $7 | $27 |
| Removal of impacted ear wax | 63 | $34 | $101 |
| Administration and interpretation of patient-focused health risk assessment | 62 | $2 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 56 | $6 | $42 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 55 | $120 | $307 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 55 | $1 | $39 |
| Joint injection, major joint | 52 | $51 | $139 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 49 | $0 | $50 |
| Injection, methylprednisolone acetate, 80 mg | 41 | $9 | $65 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 38 | $152 | $358 |
| Basic metabolic blood panel | 37 | $8 | $26 |
| Thyroid hormone, t3 measurement, free | 34 | $17 | $50 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 34 | $55 | $146 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 33 | $16 | $54 |
| Inhalation treatment for airway obstruction or sputum production | 27 | $7 | $24 |
| Administration of vaccine | 26 | $15 | $39 |
| Microsomal antibodies (autoantibody) measurement | 25 | $14 | $35 |
| Chest X-ray, 2 views | 17 | $18 | $66 |
| Phosphate level test | 17 | $5 | $25 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 15 | $0 | $20 |
| New patient office visit (30-44 min) | 14 | $57 | $403 |
| Removal of sutures or staples under anesthesia | 12 | $42 | $125 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 11 | $39 | $87 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 11 | $41 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
8.8% medium
91.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,073
Total received (2018-2024)
Avg $2,439/year across 7 years
Top 2% in FL for family medicine
70
Companies
1,019
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,067 (100.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,055
2023
$2,564
2022
$2,461
2021
$2,959
2020
$2,132
2019
$2,300
2018
$2,602
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$3,537
ABBVIE INC.
$1,306
AstraZeneca Pharmaceuticals LP
$1,252
Amgen Inc.
$1,200
Lilly USA, LLC
$966
Boehringer Ingelheim Pharmaceuticals, Inc.
$957
Novartis Pharmaceuticals Corporation
$879
Astellas Pharma US Inc
$709
AbbVie Inc.
$598
GlaxoSmithKline, LLC.
$552
PFIZER INC.
$464
SANOFI-AVENTIS U.S. LLC
$388
Janssen Pharmaceuticals, Inc
$292
AbbVie, Inc.
$289
Takeda Pharmaceuticals U.S.A., Inc.
$288
Merck Sharp & Dohme Corporation
$262
Bayer Healthcare Pharmaceuticals Inc.
$252
Allergan Inc.
$214
Amarin Pharma Inc.
$199
Allergan, Inc.
$178
Bayer HealthCare Pharmaceuticals Inc.
$153
Kowa Pharmaceuticals America, Inc.
$149
Teva Pharmaceuticals USA, Inc.
$149
IDORSIA PHARMACEUTICALS US INC
$133
Stryker Corporation
$122
Mannkind Corporation
$119
Baudax Bio Inc.
$96
Biogen, Inc.
$89
Paratek Pharmaceuticals, Inc.
$83
E.R. Squibb & Sons, L.L.C.
$74
Grifols USA, LLC
$73
Phathom Pharmaceuticals, Inc.
$67
Radius Health, Inc.
$55
Sumitomo Pharma America, Inc.
$52
Daiichi Sankyo Inc.
$49
Horizon Therapeutics plc
$48
Regeneron Healthcare Solutions, Inc.
$48
Esperion Therapeutics, Inc.
$46
Antares Pharma, Inc.
$40
Biohaven Pharmaceutical Holding Company Ltd.
$37
Janssen Scientific Affairs, LLC
$35
FIDIA PHARMA USA INC.
$33
Otsuka America Pharmaceutical, Inc.
$32
JAZZ PHARMACEUTICALS INC.
$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$30
Exact Sciences Corporation
$29
Avanir Pharmaceuticals, Inc.
$29
Abbott Laboratories
$27
Cardiovascular Systems Inc.
$25
Sunovion Pharmaceuticals Inc.
$25
Vanda Pharmaceuticals Inc.
$22
Averitas Pharma Inc.
$20
Sanofi Pasteur Inc.
$20
Xeris Pharmaceuticals, Inc.
$18
Medtronic, Inc.
$18
IBSA Pharma Inc.
$18
Lundbeck LLC
$17
Axonics, Inc.
$17
Merck Sharp & Dohme LLC
$17
Agios Pharmaceuticals, Inc.
$16
Pacira Therapeutics, Inc.
$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
ARBOR PHARMACEUTICALS, INC.
$15
Biohaven Pharmaceuticals, Inc.
$14
Medtronic MiniMed, Inc.
$14
Shield Therapeutics Inc
$14
Eisai Inc.
$13
Smith+Nephew, Inc.
$12
Bioventus LLC
$12
Clarus Therapeutics Inc.
$6
Top 3 companies account for 35.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADUHELM · ADVAIR · AFREZZA · AIRSUPRA · AJOVY · ANJESO · ANORO · ANORO ELLIPTA · Aimovig · Amitiza · Androgel · Axonics · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CAMZYOS · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · COSENTYX · CREON · CUVITRU · Cologuard Collection Kit · Creon · DUEXIS · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Entyvio · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GELSYN 3 · GEMTESA · GLYXAMBI · HETLIOZ · Hymovis · INJECTAFER · INVOKANA · JANUMET XR · JANUVIA · JARDIANCE · JATENZO · Kerendia · LANTUS · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Motegrity · Myrbetriq · NEXLETOL · NOCDURNA · NURTEC ODT · NUZYRA · NuDyn · Nuedexta · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRALUENT · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PYRUKYND · Peripheral Orbital Atherectomy System · Prolastin-C Liquid · Prolia · QTERN · QULIPTA · QUTENZA · QUVIVIQ · RECORLEV · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNCHROMEDII · SYNJARDY XR · SYNTHROID · Santyl · Saxenda · Synthroid · TALTZ · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZENPEP · Zilretta · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in FL.
Equivalent to $56 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
486
Per 100K population
85.5
County median income
$66,581
Nearest hospital
ADVENTHEALTH DELAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hill is a clinical cardiology specialist, with above-average Medicare volume (top 0% in FL), with low-engagement industry engagement in the top 2% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hill experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hill performed 3,961 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hill receive payments from pharmaceutical companies?
Yes. Dr. Hill received a total of $17,073 from 70 companies across 1,019 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hill's costs compare to other family medicine physicians in Deland?
Dr. Hill's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Deland
Browse family medicine physicians in Deland ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in FL
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in FL
Which FL family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology